Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.19.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Current assets    
Cash and cash equivalents $ 1,619 $ 626
Restricted cash 113 113
Accounts receivable, net 135,687 129,343
Costs and estimated earnings in excess of billings on uncompleted contracts 32,698 33,006
Advances to and equity in joint ventures, net 12 11
Other current assets 34,857 3,161
Total current assets 204,986 166,260
Property and equipment, net 20,527 17,918
Intangible assets, net 12,953 14,225
Goodwill 10,488 10,488
Deferred tax asset 4,409 3,664
Other assets 271 465
Total assets 253,634 213,020
Current liabilities    
Current portion of long-term debt 3,141 6,358
Accounts payable, including retainage 74,353 67,438
Billings in excess of costs and estimated earnings on uncompleted contracts 50,843 28,543
Accrued income taxes 0 2,220
Accrued expenses and other current liabilities 53,801 30,925
Total current liabilities 182,138 135,484
Long-term debt 23,614 20,556
Other long-term liabilities 1,514 861
Total liabilities 207,266 156,901
Commitments and contingencies
Redeemable convertible preferred stock, net, par value $0.0001, 1,000,000 shares authorized, no shares issued and outstanding as of December 31, 2018 and 280,000 issued and outstanding as of December 31, 2017 ($0 and $7,853 redemption value as of December 31, 2018 and December 31, 2017, respectively) 0 7,959
STOCKHOLDERS' EQUITY    
Common stock, $.0001 par value; 100,000,000 shares authorized,  7,592,911 issued and outstanding at December 31, 2018 and 7,504,133 at December 31, 2017 1 1
Additional paid-in capital 54,791 54,738
Accumulated deficit (8,424) (6,579)
Total stockholders' equity 46,368 48,160
Total liabilities and stockholders' equity $ 253,634 $ 213,020